-Shinya Minatoguchi Researcher Activity Profile

Research Author Detailed Information 

Shinya Minatoguchi Publication Rate By Year

Shinya Minatoguchi has published 14 paper(s) in 2007, 7 paper(s) in 2008, for a total of 21 research publications in total.

Shinya S Minatoguchi Author Information

LAST NAME: minatoguchi

FIRST NAME: shinya

INITIALS: S

AFFILIATION:

Papers

Shinya Minatoguchi's Publication Record

1. Amlodipine inhibits granulation tissue cell apoptosis through reducing calcineurin activity to attenuate postinfarction cardiac remodeling. Year Published: 2007
Second Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan.
2. Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits. Year Published: 2007
Second Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan.
3. Renoprotective effect of the addition of losartan to ongoing treatment with an Angiotensin converting enzyme inhibitor in type-2 diabetic patients with nephropathy. Year Published: 2007
Second Department of Internal Medicine, Gifu University School of Medicine, Japan.
4. Amlodipine inhibits granulation tissue cell apoptosis through reducing calcineurin activity to attenuate postinfarction cardiac remodeling. Year Published: 2007
Second Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan.
5. Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test. Year Published: 2007
Department of Internal Medicine, Chuno Kosei Hospital, Gifu, Japan.
6. Benefits of quantitative gated SPECT in evaluation of perioperative cardiac risk in noncardiac surgery. Year Published: 2007
Department of Cardiology, Hashima City Hospital, 3-246 Shinsei-cho, Hashima, 501-6206, Japan, yoyo1@nifty.com.
7. Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test. Year Published: 2007
Department of Internal Medicine, Chuno Kosei Hospital, Gifu, Japan.
8. Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits. Year Published: 2007
Second Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan.
9. In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. Year Published: 2007
Department of Cardiology, Regeneration and Advanced Medical Science, Gifu University, Gifu, Japan.
10. In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. Year Published: 2007
Department of Cardiology, Regeneration and Advanced Medical Science, Gifu University, Gifu, Japan.
11. Benefits of quantitative gated SPECT in evaluation of perioperative cardiac risk in noncardiac surgery. Year Published: 2007
Department of Cardiology, Hashima City Hospital, 3-246 Shinsei-cho, Hashima 501-6206, Japan. yoyo1@nifty.com
12. In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. Year Published: 2007
Department of Cardiology, Regeneration and Advanced Medical Science, Gifu University, Gifu, Japan.
13. Dual blockade of the rennin-angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis. Year Published: 2008
Second Department of Internal Medicine, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan, minatos@ccc.gifu-u.ac.jp.
14. Benefits of quantitative gated SPECT in evaluation of perioperative cardiac risk in noncardiac surgery. Year Published: 2007
Department of Cardiology, Hashima City Hospital, 3-246 Shinsei-cho, Hashima 501-6206, Japan. yoyo1@nifty.com
15. Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy. Year Published: 2008
Div. of Cardiology, Gifu Univ. Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan. gt@gifu-u.ac.jp).
16. Prospective randomized trial comparing a nitinol self-expanding coronary stent with low-pressure dilatation and a high-pressure balloon expandable bare metal stent. Year Published: 2008
Second Department of Internal Medicine, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194, Japan.
17. Renoprotective effect of the addition of losartan to ongoing treatment with an angiotensin converting enzyme inhibitor in type-2 diabetic patients with nephropathy. Year Published: 2007
Second Department of Internal Medicine, Gifu University School of Medicine, Japan.
18. Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension. Year Published: 2008
Ibi Kosei Hospital.
19. Development of integrated backscatter intravascular ultrasound for tissue characterization of coronary plaques. Year Published: 2008
Regeneration and Advanced Medical Science, Gifu University Graduate School of Medicine, Gifu, Japan.
20. Dual blockade of the rennin-angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis. Year Published: 2008
Second Department of Internal Medicine, Gifu University, 1-1 Yanagido, Gifu 501-1194, Japan.
21. Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy. Year Published: 2008
Division of Cardiology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan.